Separating glycoproteins using WAX chromatography
The separation of intact glycoproteins presents a great challenge because one glycoprotein can exhibit many isoforms with close physiochemical properties. As a result, it is difficult to study them in isolation. A team of chemists from Nanjing University, China, have tested a polymeric weak anion exchange (WAX) monolithic capillary to assess the high resolution separation of glycoprotein isoforms, to see whether this provides the desired results.
The separation of intact glycoproteins presents a great challenge because one glycoprotein can exhibit many isoforms with close physiochemical properties. As a result, it is difficult to study them in isolation. A team of chemists from Nanjing University, China, have tested a polymeric weak anion exchange (WAX) monolithic capillary to assess the high resolution separation of glycoprotein isoforms, to see whether this provides the desired results.1
First they prepared a base monolith through ring-opening polymerization between tris(2,3-epoxypropyl)isocyanurate and tri(2-aminoethyl). This was then modified through a reaction with an aqueous ammonia solution to convert the unreacted epoxide moieties into primary amino groups. The prepared monolithic capillary was characterised by morphology, pore size, hydrophilicity and reproducibility.
Various versions of the monolith were produced by changing the ratio of the two molecules, the temperature of the reaction and the concentration of the pore-generating molecule. The performance of the monolith capillary was then evaluated using several typical glycoproteins as mode analytes. Under the optimized separation conditions, the tested glycoproteins were all resolved into distinct glycoforms. The monolith’s separation ability was compared with capillary zone electrophoresis (CZE) and revealed that the WAX column separated more glycoforms, both consistently and at a faster speed, although the resolution of some glycoprotein isoforms decreased.
Reference
1 Zhen Liu et al., J. Chromatogr. A, September 2011, doi: 10.1016/j. chroma 2011.08.079
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
